FDA rejects Avanir's migraine drug-device
November 26, 2014 at 17:30 PM EST
Nov 26 (Reuters) - The U.S. Food and Drug Administration rejected Avanir Pharmaceuticals Inc's migraine drug device, a few weeks after the regulator had raised questions regarding some data submitted as part of the marketing application.
